Global Personalized Medicines In Oncology Market Growth (Status and Outlook) 2021-2026

Global Personalized Medicines In Oncology Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Medicines In Oncology Market Size 2016-2026
2.1.2 Personalized Medicines In Oncology Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Personalized Medicines In Oncology Segment by Service
2.2.1 Molecular Oncopathology
2.2.2 Molecular Oncopathology
2.2.3 Radiation Therapy
2.2.4 Oncology Testing
2.2.5 Chemotherapy
2.2.6 Others
2.3 Personalized Medicines In Oncology Market Size by Service
2.3.1 Global Personalized Medicines In Oncology Market Size CAGR by Service
2.3.2 Global Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
2.4 Personalized Medicines In Oncology Segment by End Users
2.4.1 Research Centers
2.4.2 Governmental Institutions
2.4.3 Hospitals
2.4.4 Clinical Centers
2.4.5 Others
2.5 Personalized Medicines In Oncology Market Size by End Users
2.5.1 Global Personalized Medicines In Oncology Market Size CAGR by End Users
2.5.2 Global Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)

3 Global Personalized Medicines In Oncology by Players
3.1 Personalized Medicines In Oncology Market Size Market Share by Players
3.1.1 Global Personalized Medicines In Oncology Revenue by Players (2019-2021E)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2021E)
3.2 Global Personalized Medicines In Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Personalized Medicines In Oncology by Regions
4.1 Personalized Medicines In Oncology Market Size by Regions (2016-2021)
4.2 Americas Personalized Medicines In Oncology Market Size Growth (2016-2021)
4.3 APAC Personalized Medicines In Oncology Market Size Growth (2016-2021)
4.4 Europe Personalized Medicines In Oncology Market Size Growth (2016-2021)
4.5 Middle East & Africa Personalized Medicines In Oncology Market Size Growth (2016-2021)

5 Americas
5.1 Americas Personalized Medicines In Oncology Market Size by Country (2016-2021)
5.2 Americas Personalized Medicines In Oncology Market Size by Service (2016-2021)
5.3 Americas Personalized Medicines In Oncology Market Size by End Users (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Personalized Medicines In Oncology Market Size by Region (2016-2021)
6.2 APAC Personalized Medicines In Oncology Market Size by Service (2016-2021)
6.3 APAC Personalized Medicines In Oncology Market Size by End Users (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Personalized Medicines In Oncology by Country (2016-2021)
7.2 Europe Personalized Medicines In Oncology Market Size by Service (2016-2021)
7.3 Europe Personalized Medicines In Oncology Market Size by End Users (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Personalized Medicines In Oncology by Region (2016-2021)
8.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Service (2016-2021)
8.3 Middle East & Africa Personalized Medicines In Oncology Market Size by End Users (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Personalized Medicines In Oncology Market Forecast
10.1 Global Personalized Medicines In Oncology Forecast by Regions (2021-2026)
10.1.1 Global Personalized Medicines In Oncology Forecast by Regions (2021-2026)
10.1.2 Americas Personalized Medicines In Oncology Forecast
10.1.3 APAC Personalized Medicines In Oncology Forecast
10.1.4 Europe Personalized Medicines In Oncology Forecast
10.1.5 Middle East & Africa Personalized Medicines In Oncology Forecast
10.2 Americas Personalized Medicines In Oncology Forecast by Countries (2021-2026)
10.2.1 United States Personalized Medicines In Oncology Market Forecast
10.2.2 Canada Personalized Medicines In Oncology Market Forecast
10.2.3 Mexico Personalized Medicines In Oncology Market Forecast
10.2.4 Brazil Personalized Medicines In Oncology Market Forecast
10.3 APAC Personalized Medicines In Oncology Forecast by Region (2021-2026)
10.3.1 China Personalized Medicines In Oncology Market Forecast
10.3.2 Japan Personalized Medicines In Oncology Market Forecast
10.3.3 Korea Personalized Medicines In Oncology Market Forecast
10.3.4 Southeast Asia Personalized Medicines In Oncology Market Forecast
10.3.5 India Personalized Medicines In Oncology Market Forecast
10.3.6 Australia Personalized Medicines In Oncology Market Forecast
10.4 Europe Personalized Medicines In Oncology Forecast by Country (2021-2026)
10.4.1 Germany Personalized Medicines In Oncology Market Forecast
10.4.2 France Personalized Medicines In Oncology Market Forecast
10.4.3 UK Personalized Medicines In Oncology Market Forecast
10.4.4 Italy Personalized Medicines In Oncology Market Forecast
10.4.5 Russia Personalized Medicines In Oncology Market Forecast
10.5 Middle East & Africa Personalized Medicines In Oncology Forecast by Region (2021-2026)
10.5.1 Egypt Personalized Medicines In Oncology Market Forecast
10.5.2 South Africa Personalized Medicines In Oncology Market Forecast
10.5.3 Israel Personalized Medicines In Oncology Market Forecast
10.5.4 Turkey Personalized Medicines In Oncology Market Forecast
10.5.5 GCC Countries Personalized Medicines In Oncology Market Forecast
10.6 Global Personalized Medicines In Oncology Forecast by Service (2021-2026)
10.8 Global Personalized Medicines In Oncology Forecast by End Users (2021-2026)

11 Key Players Analysis
11.1 Biotheranostics
11.1.1 Biotheranostics Company Information
11.1.2 Biotheranostics Personalized Medicines In Oncology Product Offered
11.1.3 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Biotheranostics Main Business Overview
11.1.5 Biotheranostics Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Personalized Medicines In Oncology Product Offered
11.2.3 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 DNA Link
11.3.1 DNA Link Company Information
11.3.2 DNA Link Personalized Medicines In Oncology Product Offered
11.3.3 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 DNA Link Main Business Overview
11.3.5 DNA Link Latest Developments
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Information
11.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Genomic Health, Inc.(Exact Sciences) Main Business Overview
11.4.5 Genomic Health, Inc.(Exact Sciences) Latest Developments
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Information
11.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Cypher Genomics(Human Longevity, Inc.) Main Business Overview
11.5.5 Cypher Genomics(Human Longevity, Inc.) Latest Developments
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Information
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Main Business Overview
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Information
11.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Offered
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Fulgent Genetics Main Business Overview
11.7.5 Fulgent Genetics Latest Developments
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Information
11.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Offered
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Caris Life Sciences Main Business Overview
11.8.5 Caris Life Sciences Latest Developments
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Information
11.9.2 Ariana Pharma Personalized Medicines In Oncology Product Offered
11.9.3 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Ariana Pharma Main Business Overview
11.9.5 Ariana Pharma Latest Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Information
11.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Offered
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Abbott Laboratories Main Business Overview
11.10.5 Abbott Laboratories Latest Developments
11. deCODE genetics
11.11.1 deCODE genetics Company Information
11.11.2 deCODE genetics Personalized Medicines In Oncology Product Offered
11.11.3 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 deCODE genetics Main Business Overview
11.11.5 deCODE genetics Latest Developments
11.12 Exagen Inc
11.12.1 Exagen Inc Company Information
11.12.2 Exagen Inc Personalized Medicines In Oncology Product Offered
11.12.3 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Exagen Inc Main Business Overview
11.12.5 Exagen Inc Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Personalized Medicines In Oncology Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Molecular Oncopathology
Table 3. Major Players of Genome Diagnostics
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of Oncology Testing
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Others
Table 8. Personalized Medicines In Oncology Market Size CAGR by Service (2016-2021) & ($ Millions)
Table 9. Global Personalized Medicines In Oncology Market Size by Service (2016-2021) & ($ Millions)
Table 10. Global Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Table 11. Personalized Medicines In Oncology Market Size CAGR by End Users (2016-2021) & ($ Millions)
Table 12. Global Personalized Medicines In Oncology Market Size by End Users (2016-2021) & ($ Millions)
Table 13. Global Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)
Table 14. Global Personalized Medicines In Oncology Revenue by Players (2019-2021E) & ($ Millions)
Table 15. Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2021E)
Table 16. Global Personalized Medicines In Oncology Key Players Head office and Products Offered
Table 17. Personalized Medicines In Oncology Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Personalized Medicines In Oncology Market Size by Regions 2016-2021 & ($ Millions)
Table 21. Global Personalized Medicines In Oncology Market Size Market Share by Regions 2016-2021
Table 22. Americas Personalized Medicines In Oncology Market Size by Country (2016-2021) & ($ Millions)
Table 23. Americas Personalized Medicines In Oncology Market Size Market Share by Country (2016-2021)
Table 24. Americas Personalized Medicines In Oncology Market Size by Service (2016-2021) & ($ Millions)
Table 25. Americas Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Table 26. Americas Personalized Medicines In Oncology Market Size by End Users (2016-2021) & ($ Millions)
Table 27. Americas Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)
Table 28. APAC Personalized Medicines In Oncology Market Size by Region (2016-2021) & ($ Millions)
Table 29. APAC Personalized Medicines In Oncology Market Size Market Share by Region (2016-2021)
Table 30. APAC Personalized Medicines In Oncology Market Size by Service (2016-2021) & ($ Millions)
Table 31. APAC Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Table 32. APAC Personalized Medicines In Oncology Market Size by End Users (2016-2021) & ($ Millions)
Table 33. APAC Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)
Table 34. Europe Personalized Medicines In Oncology Market Size by Country (2016-2021) & ($ Millions)
Table 35. Europe Personalized Medicines In Oncology Market Size Market Share by Country (2016-2021)
Table 36. Europe Personalized Medicines In Oncology Market Size by Service (2016-2021) & ($ Millions)
Table 37. Europe Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Table 38. Europe Personalized Medicines In Oncology Market Size by End Users (2016-2021) & ($ Millions)
Table 39. Europe Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)
Table 40. Middle East & Africa Personalized Medicines In Oncology Market Size by Region (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region (2016-2021)
Table 42. Middle East & Africa Personalized Medicines In Oncology Market Size by Service (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Table 44. Middle East & Africa Personalized Medicines In Oncology Market Size by End Users (2016-2021) & ($ Millions)
Table 45. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by End Users (2016-2021)
Table 46. Key and Potential Regions of Personalized Medicines In Oncology
Table 47. Key Application and Potential Industries of Personalized Medicines In Oncology
Table 48. Key Challenges of Personalized Medicines In Oncology
Table 49. Key Trends of Personalized Medicines In Oncology
Table 50. Global Personalized Medicines In Oncology Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 51. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Regions
Table 52. Global Personalized Medicines In Oncology Market Size Forecast by Service (2021-2026) & ($ Millions)
Table 53. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Service (2021-2026)
Table 54. Global Personalized Medicines In Oncology Market Size Forecast by End Users (2021-2026) & ($ Millions)
Table 55. Global Personalized Medicines In Oncology Market Size Market Share Forecast by End Users (2021-2026)
Table 56. Biotheranostics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 57. Biotheranostics Personalized Medicines In Oncology Product Offered
Table 58. Biotheranostics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 59. Biotheranostics Main Business
Table 60. Biotheranostics Latest Developments
Table 61. Illumina Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 62. Illumina Personalized Medicines In Oncology Product Offered
Table 63. Illumina Main Business
Table 64. Illumina Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 65. Illumina Latest Developments
Table 66. DNA Link Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 67. DNA Link Personalized Medicines In Oncology Product Offered
Table 68. DNA Link Main Business
Table 69. DNA Link Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 70. DNA Link Latest Developments
Table 71. Genomic Health, Inc.(Exact Sciences) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 72. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
Table 73. Genomic Health, Inc.(Exact Sciences) Main Business
Table 74. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 75. Genomic Health, Inc.(Exact Sciences) Latest Developments
Table 76. Cypher Genomics(Human Longevity, Inc.) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 77. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
Table 78. Cypher Genomics(Human Longevity, Inc.) Main Business
Table 79. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 80. Cypher Genomics(Human Longevity, Inc.) Latest Developments
Table 81. Life Technologies Corporation(Thermo Fisher Scientific) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 82. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
Table 83. Life Technologies Corporation(Thermo Fisher Scientific) Main Business
Table 84. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 85. Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
Table 86. Fulgent Genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 87. Fulgent Genetics Personalized Medicines In Oncology Product Offered
Table 88. Fulgent Genetics Main Business
Table 89. Fulgent Genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 90. Fulgent Genetics Latest Developments
Table 91. Caris Life Sciences Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 92. Caris Life Sciences Personalized Medicines In Oncology Product Offered
Table 93. Caris Life Sciences Main Business
Table 94. Caris Life Sciences Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 95. Caris Life Sciences Latest Developments
Table 96. Ariana Pharma Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 97. Ariana Pharma Personalized Medicines In Oncology Product Offered
Table 98. Ariana Pharma Main Business
Table 99. Ariana Pharma Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 100. Ariana Pharma Latest Developments
Table 101. Abbott Laboratories Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 102. Abbott Laboratories Personalized Medicines In Oncology Product Offered
Table 103. Abbott Laboratories Main Business
Table 104. Abbott Laboratories Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Abbott Laboratories Latest Developments
Table 106. deCODE genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 107. deCODE genetics Personalized Medicines In Oncology Product Offered
Table 108. deCODE genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 109. deCODE genetics Main Business
Table 110. deCODE genetics Latest Developments
Table 111. Exagen Inc Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 112. Exagen Inc Personalized Medicines In Oncology Product Offered
Table 113. Exagen Inc Main Business
Table 114. Exagen Inc Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 115. Exagen Inc Latest Developments
List of Figures
Figure 1. Personalized Medicines In Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicines In Oncology Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Personalized Medicines In Oncology Market Size Market Share by Service (2016-2021)
Figure 7. Personalized Medicines In Oncology in Research Centers
Figure 8. Global Personalized Medicines In Oncology Market: Research Centers (2016-2021) & ($ Millions)
Figure 9. Personalized Medicines In Oncology in Governmental Institutions
Figure 10. Global Personalized Medicines In Oncology Market: Governmental Institutions (2016-2021) & ($ Millions)
Figure 11. Personalized Medicines In Oncology in Hospitals
Figure 12. Global Personalized Medicines In Oncology Market: Hospitals (2016-2021) & ($ Millions)
Figure 13. Personalized Medicines In Oncology in Clinical Centers
Figure 14. Global Personalized Medicines In Oncology Market: Clinical Centers (2016-2021) & ($ Millions)
Figure 15. Personalized Medicines In Oncology in Others
Figure 16. Global Personalized Medicines In Oncology Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Personalized Medicines In Oncology Market Size Market Share by End Users in 2020
Figure 18. Global Personalized Medicines In Oncology Revenue Market Share by Player in 2020
Figure 19. Global Personalized Medicines In Oncology Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Personalized Medicines In Oncology Market Size 2016-2021 ($ Millions)
Figure 21. APAC Personalized Medicines In Oncology Market Size 2016-2021 ($ Millions)
Figure 22. Europe Personalized Medicines In Oncology Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Personalized Medicines In Oncology Market Size 2016-2021 ($ Millions)
Figure 24. Americas Personalized Medicines In Oncology Market Size Market Share by Country in 2020
Figure 25. Americas Personalized Medicines In Oncology Market Size Market Share by Service in 2020
Figure 26. Americas Personalized Medicines In Oncology Market Size Market Share by End Users in 2020
Figure 27. United States Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Personalized Medicines In Oncology Market Size Market Share by Regions in 2020
Figure 31. APAC Personalized Medicines In Oncology Market Size Market Share by Service in 2020
Figure 32. APAC Personalized Medicines In Oncology Market Size Market Share by End Users in 2020
Figure 33. China Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Personalized Medicines In Oncology Market Size Market Share by Countries in 2020
Figure 40. Europe Personalized Medicines In Oncology Market Size Market Share by Service in 2020
Figure 41. Europe Personalized Medicines In Oncology Market Size Market Share by End Users in 2020
Figure 42. Germany Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Service in 2020
Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by End Users in 2020
Figure 50. Egypt Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Countries Personalized Medicines In Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 56. APAC Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 57. Europe Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 59. United States Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 60. Canada Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 63. China Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 64. Japan Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 65. Korea Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 67. India Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 68. Australia Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 69. Germany Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 70. France Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 71. UK Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 72. Italy Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 73. Russia Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 74. Spain Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 77. Israel Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)
Figure 79. GCC Countries Personalized Medicines In Oncology Market Size 2021-2026 ($ Millions)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs